Sonora Investment Management Group, LLC Organon & Co. Transaction History

Sonora Investment Management Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$16.59 - $23.77 $55,642 - $79,724	3,354 Added 17.21%	22,846 $396,000
Q2 2023 Aug 10, 2023	SELL	$19.27 - $24.63 $26,746 - $34,186	-1,388 Reduced 6.65%	19,492 $405,000
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $7,968 - $11,933	372 Added 1.81%	20,880 $491,000
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $1,305 - $1,602	-56 Reduced 0.27%	20,508 $572,000
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $298,015 - $366,165	9,413 Added 84.41%	20,564 $694,000
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $339,547 - $438,903	11,151 New	11,151 $389,000

793

204M

1.71M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.72B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Sonora Investment Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Sonora Investment Management Group, LLC with notifications on news.